# A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

> **NCT06636656** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Boehringer Ingelheim** · enrollment: 45 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** BI 3032950 intravenous (Part A)
- **DRUG:** BI 3032950 subcutaneous (Part B)

## Key facts

- **NCT ID:** NCT06636656
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-12-11
- **Primary completion:** 2026-01-14
- **Final completion:** 2028-02-29
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06636656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06636656, "A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06636656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*